Back To: Home : Featured Technology : High Throughput Screening

CLICK HERE FOR WHAT'S NEW IN:
 

384/9 gene expression assay
May 2009
SHARING OPTIONS:

HTG Inc.

HTG Inc. has launched the quantitative nuclease protection assay (qNPAT) 384/9 gene expression assay. This new format enables the measurement of nine genes in a 384 well ArrayPlate and provides a higher-plex, high-throughput screening and profiling method for accelerating drug discovery and development with molecular biomarkers. This automated assay is based on HTG's proven qNPA ArrayPlate technology platform, which allows researchers to investigate a larger, customized set of genes with greater precision than traditional high throughput screening assays. The technology allows pharmaceutical researchers who handle primary and secondary screening to quickly and efficiently measure gene expression levels of mRNA and miRNA in a wide variety of cell and tissue types.

HTG Inc.
877-289-2615
www.htgenomics.com


 

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.